These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25699499)
1. In vitro emergence of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae clinical isolates. Villar HE; Santana G; Jugo MB; Perren P; Hidalgo M; Alonso P; Maccallini G J Infect Dev Ctries; 2015 Feb; 9(2):218-21. PubMed ID: 25699499 [No Abstract] [Full Text] [Related]
2. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy. Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852 [No Abstract] [Full Text] [Related]
3. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany. Shah PM Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012 [No Abstract] [Full Text] [Related]
4. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087 [TBL] [Abstract][Full Text] [Related]
13. What should be the criteria for application of modified Hodge test for carbapenemases in Klebsiella pneumoniae? Chande C; Veer P; Chivate A; Joshi SG; Chowdhary A Indian J Med Microbiol; 2013; 31(3):318-9. PubMed ID: 23883731 [No Abstract] [Full Text] [Related]
15. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Shigemoto N; Kuwahara R; Kayama S; Shimizu W; Onodera M; Yokozaki M; Hisatsune J; Kato F; Ohge H; Sugai M Diagn Microbiol Infect Dis; 2012 Jan; 72(1):109-12. PubMed ID: 22078906 [TBL] [Abstract][Full Text] [Related]
16. New Delhi metallo-β-lactamase and multidrug resistance: a global SOS? Bonomo RA Clin Infect Dis; 2011 Feb; 52(4):485-7. PubMed ID: 21258101 [No Abstract] [Full Text] [Related]
17. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Sidjabat H; Nimmo GR; Walsh TR; Binotto E; Htin A; Hayashi Y; Li J; Nation RL; George N; Paterson DL Clin Infect Dis; 2011 Feb; 52(4):481-4. PubMed ID: 21258100 [TBL] [Abstract][Full Text] [Related]
18. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835 [TBL] [Abstract][Full Text] [Related]
19. Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae. Gomez S; Pasteran F; Faccone D; Bettiol M; Veliz O; De Belder D; Rapoport M; Gatti B; Petroni A; Corso A Clin Microbiol Infect; 2013 May; 19(5):E233-5. PubMed ID: 23402333 [TBL] [Abstract][Full Text] [Related]